ART Fundamental Analysis - ARTNET AG - REG

Fundamental Rating

We assign a fundamental rating of 1 out of 10 to ART. ART was compared to 59 industry peers in the Specialty Retail industry. Both the profitability and financial health of ART have multiple concerns. ART is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

ART had negative earnings in the past year.

In the past year ART had a positive cash flow from operations.

The reported net income has been mixed in the past 5 years: ART reported negative net income in multiple years.

Each year in the past 5 years ART had a positive operating cash flow.

1.2 Ratios

ART's Return On Assets of -11.04% is on the low side compared to the rest of the industry. ART is outperformed by 79.25% of its industry peers.

ART has a Return On Equity of -38.25%. This is in the lower half of the industry: ART underperforms 75.47% of its industry peers.

		Industry Rank	Sector Rank
ROA	-11.04%
ROE	-38.25%
ROIC	N/A

ROA(3y)-5.95%

ROA(5y)-1.5%

ROE(3y)-21.15%

ROE(5y)-8.33%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 55.14%, ART belongs to the top of the industry, outperforming 83.02% of the companies in the same industry.

In the last couple of years the Gross Margin of ART has declined.

The Profit Margin and Operating Margin are not available for ART so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	55.14%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-1.76%

GM growth 5Y-3.05%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ART does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, ART has about the same amount of shares outstanding.

The number of shares outstanding for ART has been increased compared to 5 years ago.

ART has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -0.68, we must say that ART is in the distress zone and has some risk of bankruptcy.

The Altman-Z score of ART (-0.68) is worse than 73.58% of its industry peers.

ART has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.

ART's Debt to Equity ratio of 0.01 is amongst the best of the industry. ART outperforms 96.23% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.01
Debt/FCF	N/A
Altman-Z	-0.68

ROIC/WACCN/A

WACC7.21%

2.3 Liquidity

ART has a Current Ratio of 0.37. This is a bad value and indicates that ART is not financially healthy enough and could expect problems in meeting its short term obligations.

Looking at the Current ratio, with a value of 0.37, ART is doing worse than 88.68% of the companies in the same industry.

ART has a Quick Ratio of 0.37. This is a bad value and indicates that ART is not financially healthy enough and could expect problems in meeting its short term obligations.

ART's Quick ratio of 0.37 is on the low side compared to the rest of the industry. ART is outperformed by 71.70% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.37
Quick Ratio	0.37

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for ART have decreased strongly by -38.40% in the last year.

Looking at the last year, ART shows a decrease in Revenue. The Revenue has decreased by -4.74% in the last year.

The Revenue has been growing slightly by 1.83% on average over the past years.

EPS 1Y (TTM)-38.4%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%138.46%

Revenue 1Y (TTM)-4.74%

Revenue growth 3Y2.11%

Revenue growth 5Y1.83%

Sales Q2Q%-2.59%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ART. In the last year negative earnings were reported.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

66.04% of the companies in the same industry are cheaper than ART, based on the Enterprise Value to EBITDA ratio.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	56.07

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for ART!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

ARTNET AG - REG

FRA:ART (8/22/2025, 7:00:00 PM)

11.3

0 (0%)

Chartmill FA Rating

GICS SectorConsumer Discretionary

GICS IndustryGroupConsumer Discretionary Distribution & Retail

GICS IndustrySpecialty Retail

Earnings (Last)08-22 2025-08-22

Earnings (Next)09-22 2025-09-22

Inst Owners0.29%

Inst Owner ChangeN/A

Ins Owners44%

Ins Owner ChangeN/A

Market Cap64.52M

Revenue(TTM)22.24M

Net Income(TTM)-1.40M

AnalystsN/A

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	2.9
P/FCF	N/A
P/OCF	137.93
P/B	17.67
P/tB	N/A
EV/EBITDA	56.07

EPS(TTM)-0.24

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-0.2

FCFYN/A

OCF(TTM)0.08

OCFY0.73%

SpS3.9

BVpS0.64

TBVpS-0.53

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-11.04%
ROE	-38.25%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	55.14%
FCFM	N/A

ROA(3y)-5.95%

ROA(5y)-1.5%

ROE(3y)-21.15%

ROE(5y)-8.33%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-1.76%

GM growth 5Y-3.05%

F-Score3

Asset Turnover1.76

Health

		Industry Rank	Sector Rank
Debt/Equity	0.01
Debt/FCF	N/A
Debt/EBITDA	0.04
Cap/Depr	86.8%
Cap/Sales	7.34%
Interest Coverage	N/A
Cash Conversion	39.65%
Profit Quality	N/A
Current Ratio	0.37
Quick Ratio	0.37
Altman-Z	-0.68

F-Score3

WACC7.21%

ROIC/WACCN/A

Cap/Depr(3y)106.02%

Cap/Depr(5y)86.66%

Cap/Sales(3y)7.27%

Cap/Sales(5y)5.96%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-38.4%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%138.46%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-4.74%

Revenue growth 3Y2.11%

Revenue growth 5Y1.83%

Sales Q2Q%-2.59%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y35.55%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y3.38%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-59.05%

OCF growth 3Y32.03%

OCF growth 5Y-5.3%

ARTNET AG - REG / ART.DE FAQ

What is the ChartMill fundamental rating of ARTNET AG - REG (ART.DE) stock?

ChartMill assigns a fundamental rating of 1 / 10 to ART.DE.

What is the valuation status of ARTNET AG - REG (ART.DE) stock?

ChartMill assigns a valuation rating of 0 / 10 to ARTNET AG - REG (ART.DE). This can be considered as Overvalued.

Can you provide the profitability details for ARTNET AG - REG?

ARTNET AG - REG (ART.DE) has a profitability rating of 2 / 10.

What is the financial health of ARTNET AG - REG (ART.DE) stock?

The financial health rating of ARTNET AG - REG (ART.DE) is 2 / 10.

ARTNET AG - REG (ART.DE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

ARTNET AG - REG / ART.DE FAQ

What is the ChartMill fundamental rating of ARTNET AG - REG (ART.DE) stock?

What is the valuation status of ARTNET AG - REG (ART.DE) stock?

Can you provide the profitability details for ARTNET AG - REG?

What is the financial health of ARTNET AG - REG (ART.DE) stock?